Omnicin Therapeutics
Pharmaceutical Manufacturing • 
Dorkwerd, Groningen, Netherlands • 1-10 Employees
Company overview
| Headquarters | Zernikelaan 8, Groningen, 9747 AA, NL |
| Website | |
| NAICS | 3254 |
| Employees | 1-10 |
Key Contact at Omnicin Therapeutics
Auke Van Heel
CEO, Co-Founder
Omnicin Therapeutics Email Formats
Omnicin Therapeutics uses 1 email format. The most common is {first initial}{second initial}{last name} (e.g., jodoe@omnicin.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{second initial}{last name} | jodoe@omnicin.com | 100% |
About Omnicin Therapeutics
Omnicin Therapeutics is an early-stage pharmaceutical company based in the Netherlands. The company is engaged in developing therapeutic solutions to overcome antimicrobial resistance, mainly in resistant Gram-negative pathogens. Omnicin is developing OTX003, a dry-powder inhalation formulation of low-dose colloidal bismuth subcitrate that potentiates existing antibiotics to effectively treat lung infections caused by resistant P. aeruginosa.
Omnicin Therapeutics revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Omnicin Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Omnicin Therapeutics has never raised funding before.
Omnicin Therapeutics Tech Stack
Discover the technologies and tools that power Omnicin Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
Font scripts
JavaScript libraries
Jersey
Australia
United States
Germany
Italy
Frequently asked questions
4.8
40,000 users
